Navigation Links
AMPAC Fine Chemicals Continues to Invest in Quality Systems
Date:2/14/2012

RANCHO CORDOVA, Calif., Feb. 14, 2012 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly owned subsidiary of American Pacific Corporation (Nasdaq: APFC), reports that it has joined Rx-360 as an active member.  Rx-360 is a pharmaceutical and biotech industry consortium that was founded by industry leaders to enhance the security of the pharmaceutical supply chain and to assure the quality and authenticity of the products moving through the supply chain.  AFC is contributing to the Rx-360's joint audit pilot program as the first U.S.-based active pharmaceutical ingredient (API) manufacturer to be audited.

AFC's ongoing focus and commitment to quality has resulted in a successful U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) for seven oncology and anti-viral products, subsequently resulting in FDA approval for several of these products.  This is the latest of several successful inspections at the AFC Rancho Cordova, California, facility over the past year, including a combined FDA PAI and general inspection, and inspections by the Korean FDA (KFDA) and the European Medicines Agency (EMA).

"We continue to invest in our quality systems and this is demonstrated by our successful inspections by the FDA, KFDA and EMA.  In 2011, we were also re-accredited by the Japanese PMDA," stated Jeff Robinson, Vice President of Quality and Regulatory Affairs.  "With our recent inspections and active participation in Rx-360's audit program, we continue to validate our commitment to quality and transparency."

"Successful audits by various regulatory agencies coupled with AFC joining Rx-360 substantiates our commitment to Quality and to AFC's Continuous Improvement Initiative," stated Aslam Malik, President AMPAC Fine Chemicals.

ABOUT Rx-360
Rx-360 was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain.  The mission of the new organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain.  Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide.  Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety.  The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve.  To learn more about Rx-360 go to the Rx-360 website at www.Rx-360.org.

ABOUT AMPAC FINE CHEMICALS LLC
AFC is a U.S.-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers.  Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale.  In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).  AFC's operations are located in Rancho Cordova, CA and in La Porte, Texas.  Additional information about us can be obtained by visiting our web site at www.ampacfinechemicals.com.

ABOUT AMERICAN PACIFIC CORPORATION
American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets.  We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry.  For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications.  We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry.  Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals.  Additional information about us can be obtained by visiting our web site at www.apfc.com.Technical Contact:

William DuBay, Ph.D., Vice President, 

Technology and Business Development 

AMPAC Fine Chemicals 

+1 (800) 311-9668 

+1 (916) 357-6880 

 Investor Contact:

Deanna Riccardi 

American Pacific Corporation 

+1 (702) 735-2200


'/>"/>
SOURCE American Pacific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API
2. AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture
3. AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
4. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
5. Bio architecture lab technology converts seaweed to renewable fuels and chemicals
6. Reportlinker Adds Global Immunochemicals Industry
7. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
8. Agrivida Announces Collaboration With Syngenta Ventures to Deliver Low-Cost Sugars for Cellulosic Biofuels and Biochemicals
9. Chemicals study pinpoints threat to workers lungs
10. AloeSafe™ Hand Sanitizer is Free From Toxic Chemicals
11. 21st Century Biochemicals Marks Its Third Consecutive Year on the Inc. 5000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Mass. , March 29, 2017 /PRNewswire/ ... in applying mechanistic modeling to drug research ... their collaboration with Zymeworks Inc. for quantitative ... conjugate therapeutics intended for the treatment of ... supported Zymeworks previously for GLP toxicology studies ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... for cell-based assays, disperses a quarterly travel award to noteworthy scientists who will ... company announced that its new round of awards are being given to two ...
(Date:3/29/2017)... , Mar 29, 2017 Research and ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ -  GeneNews Limited ... BreastSentry™ , a new risk stratification test for breast ... lab, Innovative Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker ... and lifetime risk for developing breast cancer.   ... BreastSentry measures the ...
Breaking Biology Technology:
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
(Date:3/13/2017)... March 13, 2017 Future of security: Biometric Face Matching ... ... DERMALOGs Face Matching enables to match face pictures against each ... to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face Matching on ...
(Date:3/7/2017)... , March 7, 2017   HireVue , ... top global companies identify the best talent, faster, today ... Chief Sales Officer (CSO) and Diana Kucer ... round out a seasoned executive team poised to drive continued ... building on a year of record bookings in 2017. ...
Breaking Biology News(10 mins):